510(k) · Cleared
ClearedMedline Anti-Reflux Valve
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Medline Industries, Inc. · FEG Tube, Double Lumen For Intestinal Decompression And/Or Intubation
Cleared on Sep 18, 2013 after a 55-day review. FDA’s file for it is a 510(k) statement, which names no predicate.
- Decided
- Sep 18, 2013
- Review
- 55 days
- Class
- Class II
- Product code
- FEG
- Recalls
- None
- Predicates
- 0
FDA’s file for it is a 510(k) statement, which names no predicate.
Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FEG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against?
FDA’s file for it is a 510(k) statement, which names no predicate.
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
How does its category compare?
All FEG devicesFEG Tube, Double Lumen For Intestinal Decompression And/Or Intubation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.
FDA decisions per year · FEG
1in 2017
2026 to Oct 25, outlined.
Median 510(k) review, days · FEG
Too few FEG 510(k)s in any year since 2007 to give a median.
Recalls per year · FEG
2in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · FEG
46in 2025
MAUDE reports naming product code FEG, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 1 |
| 2009 | 0 | — | 0 | 3 |
| 2010 | 0 | — | 0 | 1 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 2 |
| 2013 | 1 | — | 0 | 2 |
| 2014 | 0 | — | 0 | 5 |
| 2015 | 0 | — | 0 | 1 |
| 2016 | 0 | — | 0 | 4 |
| 2017 | 1 | — | 0 | 13 |
| 2018 | 0 | — | 0 | 15 |
| 2019 | 0 | — | 0 | 36 |
| 2020 | 0 | — | 0 | 23 |
| 2021 | 0 | — | 0 | 27 |
| 2022 | 0 | — | 0 | 40 |
| 2023 | 0 | — | 10 | 33 |
| 2024 | 0 | — | 0 | 31 |
| 2025 | 0 | — | 2 | 46 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Medline Anti-Reflux Valve allows the vent lumen of the gastric sump tube to neutralize the vacuum pressure in the stomach when the contents are fully evacuated, but prevents stomach contents from exiting the vent lumen. This reduces the risk that healthcare workers will be exposed to potentially infectious gastric fluids and also prevents unnecessary patient bedding and gown changes.
Indications for use as stated in the FDA 510(k) statement.
https://510kreport.com/device/K132314 · printed Nov 6, 2026
Cite this page
510(k) Report. “K132314: Medline Anti-Reflux Valve.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K132314
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Page last updated Nov 3, 2026